Michail S. Lionakis

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Paul Bastard, Lindsey B. Rosen, Qian Zhang et al. · Science · 2020 · 2.8K citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Zygomycosis in a Tertiary‐Care Cancer Center in the Era of <i>Aspergillus‐</i> Active Antifungal Therapy: A Case‐Control Observational Study of 27 Recent Cases

Dimitrios P. Kontoyiannis, Michail S. Lionakis, Russell E. Lewis et al. · The Journal of Infectious Diseases · 2005 · 677 citations

Medicine, Infectious Diseases, Oncology +17

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma

Michail S. Lionakis, Kieron Dunleavy, Mark Roschewski et al. · Cancer Cell · 2017 · 499 citations · Full text

Medicine, Oncology, Pharmacology +14

The Case for Adopting the “Species Complex” Nomenclature for the Etiologic Agents of Cryptococcosis

Kyung J. Kwon‐Chung, John E. Bennett, Brian L. Wickes et al. · mSphere · 2017 · 415 citations · Full text

Life Sciences, Genetics, Microbiology +17

Inhibition of Bruton tyrosine kinase in patients with severe COVID-19

Mark Roschewski, Michail S. Lionakis, Jeff P. Sharman et al. · Science Immunology · 2020 · 380 citations · Full text

Medicine, Immunology, Pharmacology +17